Literature DB >> 21034534

Susceptibility for breast cancer in young patients with short rare minisatellite alleles of BORIS.

Se-Lyun Yoon1, Dae Choel Kim, Se Heon Cho, Sang-Yeop Lee, In-Sun Chu, Jeonghoon Heo, Sun-Hee Leem.   

Abstract

In this study, we characterized two blocks of minisatellites in the 5' upstream region of the BORIS gene (BORIS-MS1, -MS2). BORIS-MS2 was found to be polymorphic; therefore, this locus could be useful as a marker for DNA fingerprinting. We assessed the association between BORIS-MS2 and breast cancer by a case-control study with 428 controls and 793 breast cancers cases. Rare alleles in the younger group (age, <40) were associated with a statistically significant increased risk of breast cancer (odds ratio, 4.84; 95% confidence interval, 1.06-22.22; and P = 0.026). A statistically significant association between the short rare alleles and cancer was identified in the younger group (8.02; 1.01-63.83; P = 0.021). Kaplan-Meier estimates showed that poor prognosis was associated with patients who contained the rare alleles. Our data suggest that the short rare alleles of BORIS-MS2 could be used to identify the risk for breast cancer in young patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034534     DOI: 10.5483/BMBRep.2010.43.10.698

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  8 in total

1.  Association of MUC6-minisatellite variants with susceptibility to rectal carcinoma.

Authors:  Myoung-Hyun Ahn; Ki Beom Bae; Jeong-Ah Kwon; Hong-Jo Choi; Se-Ra Lee; Si-Hoon Kim; Tae Doo Jung; Sun Hee Kim; Min Sung An; Kwan Hee Hong; Jeonghoon Heo; Tae-Hong Kang; Jin Woong Chung; Sun-Hee Leem
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

2.  The hTERT-VNTR2-2nd alleles are involved in genomic stability in gastrointestinal cancer.

Authors:  Jeong-Ah Kwon; Mi-So Jeong; Se-Lyun Yoon; Jeong-Yeon Mun; Min-Hye Kim; Gi-Eun Yang; Seong-Hwan Park; Jin-Woong Chung; Yung Hyun Choi; Hee-Jae Cha; Sun-Hee Leem
Journal:  Genes Genomics       Date:  2019-11-05       Impact factor: 1.839

3.  Short rare minisatellite variant of BORIS-MS2 is related to bladder cancer susceptibility.

Authors:  Tae Nam Kim; Won-Tae Kim; Mi-So Jeong; Mi-Hye Mun; Min-Hye Kim; Jeong Zoo Lee; Sun-Hee Leem
Journal:  Genes Genomics       Date:  2018-11-29       Impact factor: 1.839

4.  Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells.

Authors:  Maria Buoncervello; Paola Borghi; Giulia Romagnoli; Francesca Spadaro; Filippo Belardelli; Elena Toschi; Lucia Gabriele
Journal:  Neoplasia       Date:  2012-09       Impact factor: 5.715

5.  Association between the length of the MUC8-minisatellite 5 region and susceptibility to chronic obstructive pulmonary disease (COPD).

Authors:  Se-Ra Lee; Won-Tae Kim; Tae Nam Kim; Jong Kil Nam; Woo Jin Kim; Sun-Hee Leem
Journal:  Genes Genomics       Date:  2017-11-09       Impact factor: 1.839

Review 6.  Expression of the epigenetic factor BORIS (CTCFL) in the human genome.

Authors:  Rosalia de Necochea-Campion; Anahit Ghochikyan; Steven F Josephs; Shelly Zacharias; Erik Woods; Feridoun Karimi-Busheri; Doru T Alexandrescu; Chien-Shing Chen; Michael G Agadjanyan; Ewa Carrier
Journal:  J Transl Med       Date:  2011-12-14       Impact factor: 5.531

7.  A polymorphic minisatellite region of BORIS regulates gene expression and its rare variants correlate with lung cancer susceptibility.

Authors:  Se-Lyun Yoon; Yun-Gil Roh; In-Sun Chu; Jeonghoon Heo; Seung Il Kim; Heekyung Chang; Tae-Hong Kang; Jin Woong Chung; Sang Seok Koh; Vladimir Larionov; Sun-Hee Leem
Journal:  Exp Mol Med       Date:  2016-07-15       Impact factor: 8.718

8.  VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer.

Authors:  Min-Hye Kim; Gi-Eun Yang; Mi-So Jeong; Jeong-Yeon Mun; Sang-Yeop Lee; Jong-Kil Nam; Yung Hyun Choi; Tae Nam Kim; Sun-Hee Leem
Journal:  BMC Med Genomics       Date:  2021-05-05       Impact factor: 3.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.